The Enzyme That Sits at the Crossroads—and How to Finally Measure It

A postdoctoral fellow in a mitochondrial disease lab once told me something that has stayed lodged in my memory for years. Her lab had spent eighteen months characterizing a novel SDHB variant identified in a family with aggressive paraganglioma. They had western blots confirming subunit expression. They had immunofluorescence showing mitochondrial localization. They had succinate and fumarate measurements by mass spectrometry. What they did not have, and what reviewers kept asking for, was direct enzymatic activity data. Not a succinate-to-fumarate ratio—which can shift for reasons entirely unrelated to SDH—but actual conversion rate. The kind of number that tells you whether the mutant enzyme still works, works partially, or has become a structural placeholder in the inner mitochondrial membrane. The question was straightforward. The answer was not.

That gap exists because succinate dehydrogenase occupies a uniquely awkward measurement niche. It is simultaneously the least glamorous of the mitochondrial complexes—no proton pumping, no clever name, no blockbuster drug—and the only enzyme that participates in both the TCA cycle and the electron transport chain. SDH catalyzes the oxidation of succinate to fumarate in the TCA cycle while transferring electrons to ubiquinone in the ETC, a dual citizenship no other Krebs cycle enzyme holds. When it fails, and its failure can be partial, the consequences cascade through both systems simultaneously. Mutations in SDH subunit genes produce a tumor spectrum that includes pheochromocytomas, paragangliomas, gastrointestinal stromal tumors, and renal cell carcinomas. Germline SDH mutations are responsible for more than 80% of familial paraganglioma aggregations. This is not a niche enzyme. It is a tumor suppressor that also happens to be a mitochondrial workhorse.

And yet most labs measure it indirectly, if they measure it at all.

Abbkine‘s CheKine™ Micro Succinate Dehydrogenase (SDH) Activity Assay Kit (KTB1230) removes the excuse. The detection principle is built on a specific, well-characterized electron transfer cascade that has been engineered for colorimetric readout. SDH in the sample catalyzes the oxidation of succinate to fumarate. The liberated electrons are transferred through phenazine methosulfate (PMS), an intermediate electron carrier, to reduce 2,6-dichlorophenolindophenol (DCPIP), which transitions from blue to colorless upon reduction. The absorbance decrease at 605 nm is monitored kinetically, and the rate of DCPIP reduction is directly proportional to SDH activity. This is not a coupled enzymatic cascade with five off-ramps for signal interference. It is a linear electron relay: succinate → SDH → PMS → DCPIP. The signal you lose at 605 nm is the signal SDH generated.

The choice of DCPIP as the terminal electron acceptor deserves attention. Researchers who have spent afternoons wrestling with ferricyanide-based SDH assays that require anaerobic conditions or with INT-based methods that produce water-insoluble formazan precipitates will immediately recognize the practical advantage. DCPIP reduction produces a soluble, colorless product measured directly in aqueous solution at 605 nm—no extraction, no organic solvent, no precipitate that clogs plate reader optics. The absorbance change is linear over a defined range, and the kit protocol specifies that ΔA should fall between 0.01 and 0.3; samples exceeding this window should be diluted. This is standard kinetic assay discipline, stated plainly.

Compatibility across biological matrices is stated with unusual specificity: animal tissues, plant tissues, cultured cells (adherent or suspension), and fungi. Plant biologists studying mitochondrial respiration under drought stress, cancer biologists characterizing SDH-deficient tumor metabolism, neurologists examining complex II dysfunction in neurodegenerative models, microbiologists profiling fungal energy metabolism—all of these workflows land in the kit‘s stated compatibility range. The product background emphasizes that SDH is not merely a mammalian enzyme but is widely present in animals, plants, microorganisms, and cultured cells, functioning as a marker enzyme of mitochondria and a film-binding enzyme located on the mitochondrial inner membrane. This cross-kingdom breadth matters when a kit is purchased by a core facility serving labs that work on everything from Arabidopsis to zebrafish.

The component list is compact: Extraction Buffer I, Extraction Buffer II, Reagent I, and Reagent II. No separate PMS solution to reconstitute, no DCPIP stock to titrate and protect from light with paranoid urgency, no substrate cocktails that require fresh preparation within two hours of use. The kit ships on gel packs with blue ice and stores stably for six months when kept according to the storage instructions. All samples and reagents should remain on ice during preparation to prevent denaturation and deactivation—a standard precaution for any enzyme activity assay that the protocol communicates explicitly.

The kit has already been cited in one publication, which the product page documents. For a metabolism assay kit, a single early citation in a peer-reviewed journal signals that at least one independent lab has validated the kit‘s performance in real experimental conditions and found the data publication-worthy. That is not a guarantee of future performance. It is, however, more informative than a manufacturer’s internal validation data that has never been exposed to reviewer scrutiny.

Several usage notes bear highlighting because they reflect thoughtful product design rather than arbitrary protocol padding. The protocol recommends calculating enzyme activity by protein concentration rather than by sample weight; if sample weight must be used, total enzyme activity equals the sum of supernatant and pellet fractions from cytoplasmic extraction. This is a meaningful distinction. Protein-normalized activity values allow comparison across samples with different cellularity and extraction efficiencies—something tissue-weight normalization cannot guarantee. The protocol also advises against testing too many samples simultaneously, because enzyme activity is calculated from the rate of absorbance change per unit time, and kinetic measurements require consistent inter-read intervals. Finally, users are instructed to extract SDH from fresh samples to ensure enzyme activity integrity, a reminder that even the best assay kit cannot rescue data from degraded starting material.

For researchers whose work intersects with mitochondrial biology, SDH activity measurement is not an esoteric add-on. It is increasingly a mandatory data category. Funding agencies reviewing grants on mitochondrial disease want to see functional validation of variants, not just sequence data. Reviewers evaluating cancer metabolism manuscripts expect direct evidence that SDH activity is altered, not just transcript levels or protein abundance. The succinate-to-fumarate ratio, while metabolically informative, can be perturbed by changes in succinate production upstream or fumarate consumption downstream—it is not a pure readout of SDH catalytic function. KTB1230 solves the specificity problem by measuring the enzyme‘s activity directly, in its native kinetic context, using a detection chemistry that has been a workhorse of SDH enzymology for decades, now packaged for a 96-well plate reader.

If your research sits at the intersection of the TCA cycle and mitochondrial respiration, this kit belongs in your freezer. The link is here: https://www.abbkine.com/product/chekine-micro-succinate-dehydrogenase-sdh-activity-assay-kit-ktb1230/